ARWR 8-K: SEC filing

Arrowhead Pharmaceuticals

Filed with the SEC on Nov 12, 2026 · accession 0000879407-26-000077

ARWR filed a 8-K (current report) with the SEC on Nov 12, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Summary of the filing

Arrowhead Pharmaceuticals announced and commented on its fiscal 2026 financial results for the period ended September 30, 2026, via a press release furnished as Exhibit 99.1 to this Form 8-K.

For details, click here →How to read a 8-K →

Key details

RegistrantArrowhead Pharmaceuticals, Inc.

Chief financial officerDaniel Apel

✦ Ask GOAX AI about this filing — what it means for ARWR, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ARWR?

Click here

Frequently asked questions

What did ARWR file with the SEC on Nov 12, 2026?

ARWR filed a 8-K (SEC filing). Arrowhead Pharmaceuticals announced and commented on its fiscal 2026 financial results for the period ended September 30, 2026, via a press release furnished as Exhibit 99.1 to this Form 8-K.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other ARWR SEC filings

Get alerts when ARWR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

ARWR overview ARWR analysis ARWR news Latest SEC filings